학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 2,449건 | 목록
1~20
Conference
2025 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) CVPR Computer Vision and Pattern Recognition (CVPR), 2025 IEEE/CVF Conference on. :11227-11238 Jun, 2025
Report
National Taiwan University Hospital; Taipei Veterans General Hospital, Taiwan; Tri-Service General Hospital; Chang Gung Medical Foundation (Linkou Branch); Taipei Medical University Shuang Ho Hospital; Koo Foundation Sun Yat-Sen Cancer Center; China Medical University Hospital; National Cheng-Kung University Hospital; Kaohsiung Medical University Chung-Ho Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital, Chiayi; Taoyuan General Hospital, Ministry of Health and Welfare; Mackay Memorial Hospital
The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer
Academic Journal
Tiew-Hwa Katherine Teng; Carolyn S.P. Lam; A. Mark Richards; Inder Anand; Chung-Lieh Hung; Lieng Hsi Ling; Houng Bang Liew; Calambur Narasimhan; Tachapong Ngarmukos; Sang Weon Park; Eugenio Reyes; Bambang B. Siswanto; Wataru Shimizu; Shu Zhang; Xiaohan Fan; Keping Chen; Liqun Wu; Yucai Xie; Qi Jin; Tianyou Ling; Xinli Li; Fang Zhou; Yanli Zhou; Dongjie Xu; Haifeng Zhang; Yangang Su; Xueying Chen; Shengmei Qin; Jingfeng Wang; Xue Gong; Zhaodi Wu; Cheuk Man Yu; B.K.S. Sastry; Arun Gopi; K. Raghu; C. Sridevi; Daljeet Kaur; Ajay Naik; Keyur Parikh; Anish Chandarana; Urmil Shah; Milan Chag; Hemang Baxi; Satya Gupta; Jyoti Bhatia; Vaishali Khakhkhar; Vineet Sankhla; Tejas Patel; Vipul Kapoor; Gurpreet Singh Wander; Rohit Tandon; Vijay Chopra; Manoj Kumar; Hatinder Jeet Singh Sethi; Rashmi Verma; Sanjay Mittal; Jitendra Sawhney; Manish Kr. Sharma; Mohanan Padinhare Purayil; Bambang Budi Siswanto; Pintoko Tedjokusumo; Erwan Martanto; null Erwinanto; Muhammad Munawar; Jimmy Agung Pambudi; Antonia Lukito; Ingrid Pardede; Alvin Thengker; Vito Damay; Siska Suridanda Danny; Rarsari Surarso; Takashi Noda; Ikutaro Nakajima; Mitsuru Wada; Kohei Ishibashi; Takashi Kurita; Ryoubun Yasuoka; Kuniya Asai; Kohji Murai; Yoshiaki Kubota; Yuki Izumi; Takanori Ikeda; Shinji Hisatake; Takayuki Kabuki; Shunsuke Kiuchi; Nobuhisa Hagiwara; Atsushi Suzuki; Tsuyoshi Suzuki; Sang-Weon Park; Suk Keun Hong; SookJin Lee; Lim Dal Soo; Dong-Hyeok Kim; Jaemin Shim; Seong-Mi Park; Seung-Young Roh; Young Hoon Kim; Mina Kim; Jong-Il Choi; Jin Oh Na; Seung Woon Rha; Hong Seog Seo; Dong Joo Oh; Chang Gyu Park; Eung Ju Kim; Sunki Lee; Boyoung Joung; Jae-Sun Uhm; Moon Hyoung Lee; In-Jeong Cho; Hui-Nam Park; Hyung-Wook Park; Jeong-Gwan Cho; Namsik Yoon; KiHong Lee; Kye Hun Kim; Seong Hwan Kim; Sahrin Saharudin; Boon Cong Beh; Yu Wei Lee; Chia How Yen; Mohd Khairi Othman; Amie-Anne Augustine; Mohd Hariz Mohd Asnawi; Roberto Angelo Mojolou; You Zhuan Tan; Aida Nurbaini Arbain; Chii Koh Wong; Razali Omar; Azmee Mohd Ghazi; Surinder Kaur Khelae; David S.P. Chew; Lok Bin Yap; Azlan Hussin; Zulkeflee Muhammad; Mohd. Ghazi Azmee; Imran Zainal Abidin; Ahmad Syadi Bin Mahmood Zhudi; Nor Ashikin Md Sari; Ganiga Srinivasaiah Sridhar; Ahmad Syadi Mahmood Zuhdi; Muhammad Dzafir Ismail; Tiong Kiam Ong; Yee Ling Cham; Ning Zan Khiew; Asri Bin Said; Alan Yean Yip Fong; Nor Hanim Mohd Amin; Keong Chua Seng; Sian Kong Tan; Kuan Leong Yew; Jones Santos; Allan Lim; Raul Lapitan; Ryan Andal; Eleanor Lopez; Kheng Leng David Sim; Boon Yew Tan; Choon Pin Lim; Louis L.Y. Teo; Laura L.H. Chan; Ping Chai; Ching Chiew Raymond Wong; Kian Keong Poh; Poh Shuan Daniel Yeo; Evelyn M. Lee; Seet Yong Loh; Min Er Ching; Deanna Z.L. Khoo; Min Sen Yew; Wenjie Huang; Kui Toh Gerard Leong; Jia Hao Jason See; Yaozong Benji Lim; Svenszeat Tan; Colin Yeo; Siang Chew Chai; Fazlur Rehman Jaufeerally; Haresh Tulsidas; Than Aung; Hean Yee Ong; Lee Fong Ling; Dinna Kar Nee Soon; Hung-I Yeh; Jen-Yuan Kuo; Chih-Hsuan Yen; Juey-Jen Hwang; Kuo-Liong Chien; Ta-Chen Su; Lian-Yu Lin; Jyh-Ming Juang; Yen-Hung Lin; Fu-Tien Chiang; Jiunn-Lee Lin; Yi-Lwun Ho; Chii-Ming Lee; Po-Chih Lin; Chi-Sheng Hung; Sheng-Nan Chang; Jou-Wei Lin; Chih-Neng Hsu; Wen-Chung Yu; Tze-Fan Chao; Shih-Hsien Sung; Kang-Ling Wang; Hsin-Bang Leu; Yenn-Jiang Lin; Shih-Lin Chang; Po-Hsun Huang; Li-Wei Lo; Cheng-Hsueh Wu; Hsin-Yueh Liang; Shih-Sheng Chang; Lien-Cheng Hsiao; Yu-Chen Wang; Chiung-Ray Lu; Hung-Pin Wu; Yen-Nien Lin; Ke-Wei Chen; Ping-Han Lo; Chung-Ho Hsu; Li-Chuan Hsieh; Mann Chandavimol; Teerapat Yingchoncharoen; Prasart Laothavorn; Waraporn Tiyanon; Wanwarang Wongcharoen; Arintaya Phrommintikul
JACC Asia
Report
National Taiwan University Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical University Chung-Ho Memorial Hospital; Taipei Veterans General Hospital, Taiwan; National Cheng-Kung University Hospital; Tri-Service General Hospital; China Medical University Hospital
Maintenance Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY)
Report
National Cheng-Kung University Hospital; National Taiwan University Hospital; Kaohsiung Medical University Chung-Ho Memorial Hospital; Taipei Veterans General Hospital, Taiwan; Chang Gung Memorial Hospital; China Medical University, Taiwan; Mackay Memorial Hospital
Phase II Trial of Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment
Report
National Taiwan University Hospital; Taipei Veterans General Hospital, Taiwan; Tri-Service General Hospital; Mackay Memorial Hospital; Chang Gung Memorial Hospital; China Medical University Hospital; Taichung Veterans General Hospital; Changhua Christian Hospital; Kaohsiung Veterans General Hospital.; National Cheng-Kung University Hospital; Kaohsiung Medical University Chung-Ho Memorial Hospital; Taoyuan General Hospital
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registration Study for Wild Type Gastrointestinal Stromal Tumor Patients (TOPICS-GIST)
Conference
Wu, Haibin; Chen, Xuanjun; Lin, Yi-Cheng; Chang, Kaiwei; Du, Jiawei; Lu, Ke-Han; Liu, Alexander H.; Chung, Ho-Lam; Wu, Yuan-Kuei; Yang, Dongchao; Liu, Songxiang; Wu, Yi-Chiao; Tan, Xu; Glass, James; Watanabe, Shinji; Lee, Hung-Yi
2024 IEEE Spoken Language Technology Workshop (SLT) Spoken Language Technology Workshop (SLT), 2024 IEEE. :570-577 Dec, 2024
Academic Journal
2025 62nd ACM/IEEE Design Automation Conference (DAC). :1-7
Academic Journal
International Journal of Economics, Finance and Management Sciences. 13:210-221
Academic Journal
IEEE Transactions on Computers. 74:2334-2347
Academic Journal
Jalil Boukhobza; Pierre Olivier; Wen Sheng Lim; Liang-Chi Chen; Yun-Shan Hsieh; Shin-Ting Wu; Chien-Chung Ho; Po-Chun Huang; Yuan-Hao Chang
ACM Transactions on Storage. 21:1-59
Conference
Kuan, Chun-Yi; Li, Chen-An; Hsu, Tsu-Yuan; Lin, Tse-Yang; Chung, Ho-Lam; Chang, Kai-Wei; Chang, Shuo-Yiin; Lee, Hung-Yi
2023 IEEE Automatic Speech Recognition and Understanding Workshop (ASRU) Automatic Speech Recognition and Understanding Workshop (ASRU), 2023 IEEE. :1-8 Dec, 2023
Report
Taipei Veterans General Hospital, Taiwan; China Medical University Hospital; National Cheng-Kung University Hospital; Kaohsiung Medical University Chung-Ho Memorial Hospital; Chang Gung Memorial Hospital
A Phase Ib/II Study of Ramucirumab (Cyramza®), Nal-IRI (ONIVYDE®) and Trifluridine/Tipiracil (Lonsurf®) in Second Line Metastatic Gastric Cancer (COOL Study).
Innocenti F, Kroetz DL, Schuetz E, Dolan ME, Ramirez J, Relling M, Chen P, Das S, Rosner GL, Ratain MJ. Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. J Clin Oncol. 2009 Jun 1;27(16):2604-14. doi: 10.1200/JCO.2008.20.6300. Epub 2009 Apr 6.
Mathijssen RH, van Alphen RJ, Verweij J, Loos WJ, Nooter K, Stoter G, Sparreboom A. Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Clin Cancer Res. 2001 Aug;7(8):2182-94.
Smith NF, Figg WD, Sparreboom A. Pharmacogenetics of irinotecan metabolism and transport: an update. Toxicol In Vitro. 2006 Mar;20(2):163-75. doi: 10.1016/j.tiv.2005.06.045. Epub 2005 Nov 3.
Kawato Y, Aonuma M, Hirota Y, Kuga H, Sato K. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res. 1991 Aug 15;51(16):4187-91.
Garcia-Carbonero R, Supko JG. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin Cancer Res. 2002 Mar;8(3):641-61.
Vanhoefer U, Harstrick A, Achterrath W, Cao S, Seeber S, Rustum YM. Irinotecan in the treatment of colorectal cancer: clinical overview. J Clin Oncol. 2001 Mar 1;19(5):1501-18. doi: 10.1200/JCO.2001.19.5.1501.
Lee DH, Kim HT, Han JY, Lee SY, Yoon SJ, Kim HY, Lee JS. A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naive patients with metastatic or recurrent squamous cell carcinoma of the esophagus. Cancer Chemother Pharmacol. 2008 Jan;61(1):83-8. doi: 10.1007/s00280-007-0450-7. Epub 2007 Apr 28.
Chen SC,Chang PM, Yang MH. Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study. Oncologist. 2016 May;21(5):537-8. doi: 10.1634/theoncologist.2015-0515. Epub 2016 Apr 18.
Tsai CS, Park JW, Chen LT. Nanovector-based therapies in advanced pancreatic cancer. J Gastrointest Oncol. 2011 Sep;2(3):185-94. doi: 10.3978/j.issn.2078-6891.2011.034.
Chang TC, Shiah HS, Yang CH, Yeh KH, Cheng AL, Shen BN, Wang YW, Yeh CG, Chiang NJ, Chang JY, Chen LT. Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients. Cancer Chemother Pharmacol. 2015 Mar;75(3):579-86. doi: 10.1007/s00280-014-2671-x. Epub 2015 Jan 11.
Chiang NJ, Chao TY, Hsieh RK, Wang CH, Wang YW, Yeh CG, Chen LT. A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors. BMC Cancer. 2016 Nov 21;16(1):907. doi: 10.1186/s12885-016-2933-6.
Roy AC, Park SR, Cunningham D, Kang YK, Chao Y, Chen LT, Rees C, Lim HY, Tabernero J, Ramos FJ, Kujundzic M, Cardic MB, Yeh CG, de Gramont A. A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma. Ann Oncol. 2013 Jun;24(6):1567-73. doi: 10.1093/annonc/mdt002. Epub 2013 Feb 13.
Ko AH, Tempero MA, Shan YS, Su WC, Lin YL, Dito E, Ong A, Wang YW, Yeh CG, Chen LT. A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer. Br J Cancer. 2013 Aug 20;109(4):920-5. doi: 10.1038/bjc.2013.408. Epub 2013 Jul 23.
Wang-Gillam A, Li CP, Bodoky G, Dean A, Shan YS, Jameson G, Macarulla T, Lee KH, Cunningham D, Blanc JF, Hubner RA, Chiu CF, Schwartsmann G, Siveke JT, Braiteh F, Moyo V, Belanger B, Dhindsa N, Bayever E, Von Hoff DD, Chen LT; NAPOLI-1 Study Group. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet. 2016 Feb 6;387(10018):545-557. doi: 10.1016/S0140-6736(15)00986-1. Epub 2015 Nov 29.
Innocenti F, Kroetz DL, Schuetz E, Dolan ME, Ramirez J, Relling M, Chen P, Das S, Rosner GL, Ratain MJ. Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. J Clin Oncol. 2009 Jun 1;27(16):2604-14. doi: 10.1200/JCO.2008.20.6300. Epub 2009 Apr 6.
Mathijssen RH, van Alphen RJ, Verweij J, Loos WJ, Nooter K, Stoter G, Sparreboom A. Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Clin Cancer Res. 2001 Aug;7(8):2182-94.
Smith NF, Figg WD, Sparreboom A. Pharmacogenetics of irinotecan metabolism and transport: an update. Toxicol In Vitro. 2006 Mar;20(2):163-75. doi: 10.1016/j.tiv.2005.06.045. Epub 2005 Nov 3.
Kawato Y, Aonuma M, Hirota Y, Kuga H, Sato K. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res. 1991 Aug 15;51(16):4187-91.
Garcia-Carbonero R, Supko JG. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin Cancer Res. 2002 Mar;8(3):641-61.
Vanhoefer U, Harstrick A, Achterrath W, Cao S, Seeber S, Rustum YM. Irinotecan in the treatment of colorectal cancer: clinical overview. J Clin Oncol. 2001 Mar 1;19(5):1501-18. doi: 10.1200/JCO.2001.19.5.1501.
Lee DH, Kim HT, Han JY, Lee SY, Yoon SJ, Kim HY, Lee JS. A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naive patients with metastatic or recurrent squamous cell carcinoma of the esophagus. Cancer Chemother Pharmacol. 2008 Jan;61(1):83-8. doi: 10.1007/s00280-007-0450-7. Epub 2007 Apr 28.
Chen SC,
Tsai CS, Park JW, Chen LT. Nanovector-based therapies in advanced pancreatic cancer. J Gastrointest Oncol. 2011 Sep;2(3):185-94. doi: 10.3978/j.issn.2078-6891.2011.034.
Chiang NJ, Chao TY, Hsieh RK, Wang CH, Wang YW, Yeh CG, Chen LT. A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors. BMC Cancer. 2016 Nov 21;16(1):907. doi: 10.1186/s12885-016-2933-6.
Roy AC, Park SR, Cunningham D, Kang YK, Chao Y, Chen LT, Rees C, Lim HY, Tabernero J, Ramos FJ, Kujundzic M, Cardic MB, Yeh CG, de Gramont A. A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma. Ann Oncol. 2013 Jun;24(6):1567-73. doi: 10.1093/annonc/mdt002. Epub 2013 Feb 13.
Ko AH, Tempero MA, Shan YS, Su WC, Lin YL, Dito E, Ong A, Wang YW, Yeh CG, Chen LT. A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer. Br J Cancer. 2013 Aug 20;109(4):920-5. doi: 10.1038/bjc.2013.408. Epub 2013 Jul 23.
Wang-Gillam A, Li CP, Bodoky G, Dean A, Shan YS, Jameson G, Macarulla T, Lee KH, Cunningham D, Blanc JF, Hubner RA, Chiu CF, Schwartsmann G, Siveke JT, Braiteh F, Moyo V, Belanger B, Dhindsa N, Bayever E, Von Hoff DD, Chen LT; NAPOLI-1 Study Group. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet. 2016 Feb 6;387(10018):545-557. doi: 10.1016/S0140-6736(15)00986-1. Epub 2015 Nov 29.
Report
Taipei Veterans General Hospital, Taiwan; Chang Gung Memorial Hospital; China Medical University Hospital; National Cheng-Kung University Hospital; Kaohsiung Medical University Chung-Ho Memorial Hospital
A Phase I/II Study of Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinoma
Report
Taipei Veterans General Hospital, Taiwan; Chang Gung Memorial Hospital; China Medical University Hospital; National Cheng-Kung University Hospital; Kaohsiung Medical University Chung-Ho Memorial Hospital; National Taiwan University Hospital
A Study of Nivolumab Combination Gemcitabine and S1 as the First-Line Treatment in Patients With Advanced Biliary Tract Cancer
Chiang NJ, Tang CY, Bai LY,Chang PC, Chen WM, Kang ST, Chen SC, Chen MH, Hsieh JC. Circulating miRNAs as potentially predictive biomarkers for chemoimmunotherapy in advanced biliary tract cancer: a post-hoc analysis of the phase II T1219 study. NPJ Precis Oncol. 2025 Aug 30;9(1):307. doi: 10.1038/s41698-025-01099-x.
Chiang NJ, Tang CY, Bai LY,
Conference
2024 International Conference on Artificial Intelligence in Information and Communication (ICAIIC) Artificial Intelligence in Information and Communication (ICAIIC), 2024 International Conference on. :1-6 Feb, 2024
Academic Journal
Katherine H. Chiang; Yen-Chung Ho; Ming-Yen Chuang; Chih-Yu Chang; Yun-Feng Kao; Hsin-Yi Yang; Chien-Hua Huang; Yu-Jen Chien; Yin-Hao Wu; Yi-Ching Liu; Hiroki Noguchi; Cheng-Jun Wu; Wai-Kit Lee; Chen-Han Chou; Pei-Jean Liao; Yu-Chien Chiu; Ya-Yun Cheng; Yu-Ming Lin; Yih Wang; Jonathan Chang; Chung-Te Lin; Min Cao
2025 Symposium on VLSI Technology and Circuits (VLSI Technology and Circuits). :1-3
검색 결과 제한하기
제한된 항목
[검색어] Chang, Chung-Ho
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어